Find a Top Psychiatrist Near Me in Gaithersburg, MD – Book an Appointment Instantly

Psychiatric Resident Physician

Education

Current: Psychiatry Resident - George Washington University, Washington, DC

Medical School: University of South Florida Morsani College of Medicine

Publications

Mirza, S., Yun, S., Al Ali, N., Shin, H., O'Neill, J. L., Schwartz, D., Kuc, A., Abusrur, S., Jesurajan, J., Kuang, J., Patel, S., Khalil, S., Bhaskar, S., Beard, A., Abuelenen, T., Nowell, E., Ratnasamy, K., Visweshwar, N., Komrokji, R. S., & Jaglal, M. (2018). Incidence, Risk, and Markers of Thrombosis in AML Patients - Single Institution Experience. Blood, 132(Suppl 1), 5880. Accessed November 21, 2018. https://doi.org/10.1182/blood-2018-99-120332.

Presentations

May 13th, 2022

“When the challenges to health are so loud, it is deafening: a case report”

AGS Annual Scientific Meeting 2022

February 25th, 2019

“Pupil Diameter During a Visual Acuity test”

USF Health Research Day 2019

April 6th, 2017

“Patient-Physician Interaction in the Emergency Department”

USF Undergraduate Research Conference 2018

April 2nd, 2016

“The Bioactivity Study of Antibiotic Loaded Chiral Polymer Nanoparticle Emulsions”
Raymond N. Castle Student Research Conference

Awards

May 13th, 2022
Resident Poster Award, 1st Place, Category: Case Studies
     American Geriatrics Society 2022 Annual Scientific Meeting – Orlando, FL

April 10th, 2020

Gold Humanism Award

Education

Currently: Clinical Fellow at National Institute of Mental Health

Residency: Medical University of South Carolina 

Medical School: Yale School of Medicine

 

CONFERENCE AND ABSTRACTS

1. Zou CX, Becker JE, Phillips AT, Krumholz HM, Miller JE, Ross JS. Impact of FDAAA on Registration, Results Reporting and Publication of Neuropsychiatric Clinical Trials Supporting FDA New Drug Approval, 2005-2014. Podium Presentation, 2017, Eighth Peer Review Congress, Chicago, IL

1. Basturk O, Wei JJ, Kong J, Zou X*, Peng Y, Melamed J, Lee P. MicroRNA Expression in Androgen Independent and Metastatic Prostate Cancer. In: Proceedings of the United States and Canadian Academy of Pathology Annual Meeting 2008, 2008 March 1-7. Denver, CO
2. Newman KK, Wang BY, Cetin N, Ye H, Zou X*, Lee P, Melamed J. Differential Steroid Hormone Expression in Renal Cell Carcinoma Subtypes. In: Proceedings of the United States and Canadian Academy of Pathology Annual Meeting 2009. March 7-13. Boston, MA
3. Pan LY, Wei JJ, Patwa RR, Ligr M, Jain S, Zou XY*, Daniels G, Li YR, Xu RL, Sun W, Wang ZX, Lee P, Chen F. Androgen Receptor Coactivator p44/Mep50 in Ovarian Cancer. In: Proceedings of the United States and Canadian Academy of Pathology Annual Meeting 2010. March 20-26, Washington DC

 

PUBLICATIONS

1. Zou CX, Becker JE, Phillips AT, Garritano JM, Krumholz HM, Miller JE, Ross JS. Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study. Trials 2018 Oct 23;19(1):581
2. Phillips AT, Desai, NR, Zou CX, Miller JE, Ross JS. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting. Trials. 2017 July 18:333
3. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X*, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic D, Polsky D, Wei J, Lee P, Belitskaya-Levy I, Bhardwaj N, Osman I, Hernando E. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1814-9.
4. Li Y, Wang L, Zhang M, Melamed J, Liu X, Reiter R, Wei J, Peng Y, Zou X*, Pellicer A, Garabedian MJ, Ferrari A, Lee P. LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion. Cancer Res. 2009 Apr 15;69(8):3332-8.
5. Shi G, Perle MA, Mittal K, Chen H, Zou X*, Hernando E, Lee P, Wei JJ. J Cell Mol Med. 2008 Oct 13. Let-7 repression leads to HMGA2 overexpression in uterine leiomyosarcoma. J Cell Mol Med. 13(9B):3898-905 2008 Oct 13.
6. Peng Y, Li Y, Gellert LL, Zou X*, Wang J, Singh B, Xu R, Chiriboga L, Daniels G, Pan R, Zhang DY, Garabedian M, Schneider R, Wang Z, Lee P. Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion. J Cell Mol Med. 2009 Oct 16.
7. Wang L, Zou X*, Berger AD, Twiss C, Peng Y, Li Y, Chiu J, Guo H, Satagopan J, Wilton A, Gerald W, Basch R, Wang Z, Osman I, Lee P. Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA. Am J Transl Res. 2009;1(1):62-71.
8. Ligr M, Li Y, Zou X*, Daniels G, Melamed J, Peng Y, Wang W, Wang J, Ostrer H, Pagano M, Wang Z, Garabedian MJ, Lee P. Tumor suppressor function of androgen receptor coactivator ARA70alpha in prostate cancer. Am J Pathol. 2010 Apr;176(4):1891-900.
9. Hatcher DL, Daniels G, Lin L, Basturk O, Zou X, Ostrer H, Epithelial and stromal microRNA expression in racial disparity of prostate cancer. J Urology. 2009 April;181(4) Supplement773–774
10. Mahajan A, Liu Z, Gellert L, Zou X*, Yang G, Lee P, Yang X, Wei JJ. HMGA2: A biomarker significantly overexpressed in high-grade ovarian serous carcinoma. Mod Pathol. 2010 May;23(5):673-81.
11. Monaco ME, Creighton CJ, Lee P, Zou X*, Topham MK, Stafforini DM. Expression of long-chain fatty acyl-coA synthetase 4 in breast and prostate cancers is associated with sex steroid hormone receptor negativity. Transl Oncol. 2010 Apr;3(2):91-8.
12. Wu X, Chen F, Sahin A, Albarracin C, Pei Z, Zou X*, Singh B, Xu R, Daniels G, Li Y, Wei J, Blake M, Schneider RJ, Cowin P, Lee P.Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer. Breast Cancer Res Treat. 2011 Jul;128(2):391-400.
13. Wang L, Zou X*, Berger AD, Twiss C, Peng Y, Li Y, Chiu J, Guo H, Satagopan J, Wilton A, Gerald W, Basch R, Wang Z, Osman I, Lee P. Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA. 2009;1(1):62-71.

 

AWARDS

General Scholar, American Association of Geriatric Psychiatry                                                                               2017

Fellowship award, National Institute of Blood, Lung, and Heart, Bethesda, MD                             2016

Mila Rainof, M.D. Memorial Scholarship, Yale School of Medicine, New Haven, CT                                  2015, 2016

Disadvantaged Merit Scholarship, Yale School of Medicine, New Haven, CT                                                2015-2019

Member of Phi Beta Kappa, Columbia University Chapter, New York, NY                                    2014-present

Member of School of General Studies Honors Society, Columbia University, New York, NY                               2013

Best Thesis, China Agricultural University, Beijing                                                                                                                  2007

Member of Presidential Honors Program, China Agricultural University, Beijing                                       2003-2007

I am a board-certified Psychiatric-Mental Health Nurse Practitioner (PMHNP) who is passionate about mental health care. I am committed to providing compassionate and evidence-based treatment to individuals seeking support for their mental well-being. I work with children, adolescents, and adults with all mental health concerns, including mood and anxiety disorders, trauma-related conditions, and adjustment difficulties. I believe in a holistic approach to mental health, recognizing the interconnectedness of emotional, physical, and social well-being. My treatment approach is rooted in evidence-based practices, and I strongly believe in collaborating with my clients to develop personalized treatment goals and plans. Empowering individuals to actively participate in their mental health journey is vital to achieving long-lasting positive outcomes. I aim to create a safe, non-judgmental space where clients can freely explore their thoughts and emotions.

Christine is a Board Certified Psychiatric Mental Health Nurse Practitioner, who has experience treating patients across the life span. Christine received her Doctor of Nursing Practice from the University of Delaware, specializing in psychiatry/mental health. Her doctoral project was on mindfulness in substance use disorders. Christine has worked in the outpatient mental health setting since 2019. During that time, she has treated patients with a variety of mental health conditions. Prior to working in the outpatient mental health setting, Christine was a critical care registered nurse rotating between five specialty intensive care units in a large health system. During this time, she helped treat and advocate for clients with acute and chronic psychiatric conditions in the setting of an acute medical illness. Christine sees patients of all ages and treats all mental health issues.

Marlaine Registe is a board certified Psychiatric-Mental Health, and Family Nurse Practitioner based in Washington, DC, Maryland and Virginia. She earned her degree at Florida State University, where she specialized in Family/Internal Medicine. With a sub-specialty in adult, child, and adolescent psychiatry, from Shenandoah University. She has several years of experience in community health, outpatient clinics, and inpatient hospitals. Her areas of expertise include depression, bipolar disorder, anxiety disorders, ADHD, OCD, PTSD, and perinatal/postpartum. Marlaine practices collaboratively, treating the whole person & supporting all of her patients to achieve their mental health goals. Outside work, she can be found spending time with family, gardening, and traveling. She looks forward to being a part of your journey.

Marlaine Registe is a board certified Psychiatric-Mental Health, and Family Nurse Practitioner based in Washington, DC, Maryland and Virginia. She earned her degree at Florida State University, where she specialized in Family/Internal Medicine. With a sub-specialty in adult, child, and adolescent psychiatry, from Shenandoah University. She has several years of experience in community health, outpatient clinics, and inpatient hospitals. Her areas of expertise include depression, bipolar disorder, anxiety disorders, ADHD, OCD, PTSD, and perinatal/postpartum. Marlaine practices collaboratively, treating the whole person & supporting all of her patients to achieve their mental health goals. Outside work, she can be found spending time with family, gardening, and traveling. She looks forward to being a part of your journey.

New Era Recovery and Behavioral Health LLC in Washington, DC, offers integrative behavioral health care to children, teens, and adults challenged by the spectrum of mental health disorders. Gregory Obiwuma, DNP, PMHNP-BC, MSN, BSN, RN, and his experienced team offer access to quality care with the option of in-patient office visits and the convenience of virtual telehealth appointments.

The practice offers evidence-based psychiatric and behavioral health care provided by licensed and well-experienced individuals. Their client-centered approach ensures the team targets each person’s unique needs, supporting their ability to overcome mental health challenges, achieve recovery, and enjoy a thriving, balanced life.

The team aims to eradicate the stigma against behavioral health issues and promote non-judgmental mental health care.

Their comprehensive services include psychiatric evaluations, medication management, psychotherapy, and COVID-19 testing. To ensure optimal medication results, they perform GeneSight® testing, analyzing each person’s DNA to learn how their body metabolizes medications and identify the most effective ones.

Patients often seek help from the New Era Recovery and Behavioral Health LLC team for attention-deficit/hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), depression, and anxiety. The team also has extensive experience effectively treating serious mental health conditions such as bipolar disorder and schizophrenia.

People struggling with substance abuse can get outpatient treatment at New Era Recovery and Behavioral Health LLC. The team provides medication-assisted treatment that stops cravings for and withdrawal from addictions to opioids, alcohol, and other substances.

Whether patients need guidance, support, encouragement, or more intensive therapy, the team at New Era Recovery and Behavioral Health LLC is ready to help each person recover and move forward into a thriving, balanced life. To learn more about their services, call the office or use the online booking feature today.

Harish Goyal, MD is a psychiatrist providing care to older adolescents, adults and elderly patients in Northern Virginia, DC and Maryland. Dr. Goyal completed his residency in psychiatry at the University of North Dakota, Fargo where he served as the chief resident in 4th year of his residency. He was elected for Alpha Omega Alpha honor society based on trustworthiness, knowledge, proficiency in doctor-patient relationship, caring attitude towards patients. He is board certified in psychiatry.

Anandraj (Andy) Mattai, MD, is a psychiatrist and founder of Innovative Psychiatry, LLC, in Columbia, Maryland. With an exceptional bedside manner and years of experience in his field, Dr. Mattai provides top-tier psychiatric care using the latest testing methods and treatment strategies. 

Dr. Mattai excelled in school and graduated summa cum laude from Knox College in Galesburg, Illinois, before attending the University of Iowa Carver College of Medicine in Iowa City, Iowa. He then completed his psychiatric residency at Creighton University and the University of Nebraska College of Medicine, both in Omaha, Nebraska. 

After completing his residency training, Dr. Mattai pursued a clinical fellowship at the National Institute of Mental Health (NIH) in Bethesda, Maryland, where he served as an investigator on several studies. He has also since held various positions in the pharmaceutical industry. He is currently a drug development consultant.

Dr. Mattai specializes in treating a range of conditions, including OCD, ADHD, anxiety, and depression. He strives to offer his patients cutting-edge treatment options and testing methods, including GeneSight® pharmacogenomic testing, the Test of Variables of Attention (T.O.V.A.®) testing, and transcranial magnetic stimulation (TMS) for treatment-resistant depression and OCD. 

Dr. Mattai warmly welcomes new and returning patients to Innovative Psychiatry, LLC, for individualized, integrative mental health care.